SECURITIES AND EXCHANGE COMMISSION
Washington, DC20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2012
Commission File Number: 000-53750
PROTEONOMIX, INC.
(Name of Registrant in Its Charter)
Delaware (State or Other Jurisdiction ofIncorporation or Organization) | 45-5185575 (I.R.S. Employer Identification No.) |
145 Highview Terrace, Hawthorne, NJ 07506
(Address of Principal Executive Offices) (Zip Code)
(973) 544-6116
(Issuer’s Telephone Number, Including Area Code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 – Other Events
Item 8.01 Other Events
On April 24, 2012, the Registrant received a subpoena from the U.S. Securities and Exchange Commission for a number of documents and correspondence pursuant to a formal investigation of the Registrant. Proteonomix is unaware of the specific nature of this investigation and intends to cooperate fully.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PROTEONOMIX, INC.
Dated: May 2, 2012
By:/s/Michael Cohen
Name: Michael Cohen
President